Dasatinib
Catalog Number | Z10-101-138 |
Alternative Name(s) | Dasatinib(BMS-354825),BMS-354825,N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide,5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-,Dasatinib,N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide,N-(2-chloro-6-methylphenyl)-2-(6-(4-( |
Research Area | A new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic. Anti-tumor. |
Molecular Formula | C22H28ClN7O3S |
CAS# | 302962-49-8 |
Purity | >95% |
Size | Inquiry |
Supplier Page | https://www.creative-peptides.com/product/dasatinib-item-z10-101-138-6168.html |